| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 06/23/2011 | US20110152173 TNF-a ANTAGONIST MULTI-TARGET BINDING PROTEINS |
| 06/23/2011 | US20110152171 Histamine binding protein |
| 06/23/2011 | US20110152169 Sparc anti-inflammatory activity and uses thereof |
| 06/23/2011 | US20110151434 Adeno-associated virus (aav) sequences and isolating novel sequences identified thereby |
| 06/23/2011 | US20110151032 Topical anti-inflammatory combination |
| 06/23/2011 | US20110151031 Compositions and methods for utilizing the same |
| 06/23/2011 | US20110151030 Compositions for alleviating inflammation and oxidative stress in a mammal |
| 06/23/2011 | US20110151024 Compositions and Methods for Preventing Migraines |
| 06/23/2011 | US20110150991 Abuse resistant drugs, method of use and method of making |
| 06/23/2011 | US20110150990 Abuse resistant drugs, method of use and method of making |
| 06/23/2011 | US20110150978 Ph-sensitive block copolymer forming polyionic complex micelles and drug or protein carrier using the same |
| 06/23/2011 | US20110150975 Treatment of Mammalian Physiological Reaction of IgE Antibodies Present in Said Mammal Upon Contact With the Corresponding Antigen |
| 06/23/2011 | US20110150972 Medical devices having improved performance |
| 06/23/2011 | US20110150917 Small Cationic Antimicrobial Peptides |
| 06/23/2011 | US20110150902 Treating cancer |
| 06/23/2011 | US20110150891 Methods of Treating Interstitial Cystitis |
| 06/23/2011 | US20110150888 Anti-hepcidin antibodies and methods of use |
| 06/23/2011 | US20110150884 Crystalline composition of gm-csf/gm-csfr |
| 06/23/2011 | US20110150873 Anti-inflammatory compositions and combinations |
| 06/23/2011 | US20110150872 Soluble heterodimeric cytokine receptor |
| 06/23/2011 | US20110150867 Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods |
| 06/23/2011 | US20110150864 Substituted aminothiazolone indazoles as estrogen related receptor-alpha modulators |
| 06/23/2011 | US20110150863 Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides |
| 06/23/2011 | US20110150855 Enzyme Composition and Use Thereof |
| 06/23/2011 | US20110150834 Crth2 modulators |
| 06/23/2011 | US20110150833 Benzopyrans and analogs as rho kinase inhibitors |
| 06/23/2011 | US20110150825 Uses of selective inhibitors of hdac8 for treatment of inflammatory conditions |
| 06/23/2011 | US20110150785 Light Inhibitors For Asthma, Lung and Airway Inflammation, Respiratory, Interstitial, Pulmonary and Fibrotic Disease Treatment |
| 06/23/2011 | US20110150769 Identification and use of compounds for treating persistent pain |
| 06/23/2011 | US20110150763 Triazine derivatives and their therapeutical applications |
| 06/23/2011 | US20110150761 Polypeptides, polynucleotides encoding same, antibodies thereagainst and methods of using same for diagnosing and treating cancer and skeletal disorders |
| 06/23/2011 | US20110150757 Compounds for inhibiting ksp kinesin activity |
| 06/23/2011 | US20110146671 Pharmaceutical compositions and methods of delivering the same |
| 06/23/2011 | US20110145970 Detection and use of low molecular-weight modulators of the cold-menthol receptor trpm8 |
| 06/23/2011 | CA2784785A1 Methods and compositions for treating inflammation of skin |
| 06/23/2011 | CA2784133A1 Felbinac-containing transdermally absorbable preparation |
| 06/23/2011 | CA2784075A1 Inhibitors of sphingosine kinase |
| 06/23/2011 | CA2783964A1 Piroxicam-containing transdermally absorbable preparation |
| 06/23/2011 | CA2783569A1 Transdermally absorbable preparation containing basic anti-inflammatory analgesic |
| 06/23/2011 | CA2782889A1 Aminopyrimidines as syk inhibitors |
| 06/23/2011 | CA2782720A1 Pyrrolo[2,3-d]pyrimidine compounds |
| 06/23/2011 | CA2782464A1 New ccr2 receptor antagonists and uses thereof |
| 06/23/2011 | CA2780290A1 Mk2 inhibitors |
| 06/22/2011 | EP2336321A1 Ox2 receptor homolog |
| 06/22/2011 | EP2336301A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 06/22/2011 | EP2336300A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 06/22/2011 | EP2336299A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 06/22/2011 | EP2336187A2 Compositions and methods of monoclonal and polyclonal antibodies specific for T cell subpopulations |
| 06/22/2011 | EP2336184A2 Administration of agents for the treatment of inflammation |
| 06/22/2011 | EP2336168A1 Novel protein and method for producing the protein |
| 06/22/2011 | EP2336167A1 MHC molecule constructs and their uses for diagnosis and therapy |
| 06/22/2011 | EP2336133A1 Purine analogs having HSP90-inhibiting activity |
| 06/22/2011 | EP2336120A1 Combinations containing amide substituted indazoles as poly(ADP-ribose)polymerase (PARP) inhibitors |
| 06/22/2011 | EP2336111A1 Heterocyclic inhibitors of p38 |
| 06/22/2011 | EP2336109A1 Novel pyrrolinone derivative and medicinal composition containing same |
| 06/22/2011 | EP2335734A2 Treatment of pain and other alpha 2 adrenergic-mediated conditions |
| 06/22/2011 | EP2335726A1 Fusion molecules and methods for treatment of immune diseases |
| 06/22/2011 | EP2334676A1 Substituted 3 -amin0- 1-0x0 or thioxo-i, 2,5,6,7, 8-hexahydr0-2, 7-naphthyridine-4-carb0nitriles as selective alpha 2b antagonists |
| 06/22/2011 | EP2334674A1 Pyridazino- pyridinone compounds for the treatment of protein kinase mediated diseases. |
| 06/22/2011 | EP2334673A1 PYRIDO[3,2-d]PYRIDAZINE-2(1H)-ONE COMPOUNDS AS P38 MODULATORS AND METHODS OF USE THEREOF |
| 06/22/2011 | EP2334672A1 New compounds i |
| 06/22/2011 | EP2334671A1 Cyclopentathiophene modulators of the glucocorticoid receptor, ap-1, and/or nf-kappa b activity and use thereof |
| 06/22/2011 | EP2334670A1 New 2-amidothiadiazole derivatives |
| 06/22/2011 | EP2334664A1 1h-benzimidazole-5-carboxamides as anti-inflammatory agents |
| 06/22/2011 | EP2334652A1 1h-benz imidazole-5-carboxamides as anti-inflammatory agents |
| 06/22/2011 | EP2334637A1 Novel potassium channel blockers |
| 06/22/2011 | EP2334315A2 Agents and methods for treatment of pain |
| 06/22/2011 | EP2334313A1 Homeopathic therapeutic method |
| 06/22/2011 | EP2334312A1 Compositions comprising plant extracts and use thereof for treating inflammation |
| 06/22/2011 | EP2334301A1 Macrocyclics pyrimidines as aurora kinase inhibitors |
| 06/22/2011 | EP2334300A2 Composition and method for treatment of preterm labor |
| 06/22/2011 | EP2334180A1 Alleviating disorders with combining agents that increase epoxygenated fatty acids and agents that increase camp |
| 06/22/2011 | EP1950219B1 Novel dihydropseudoerythromycin derivatives |
| 06/22/2011 | EP1616856B1 Novel transcriptional factor, process for producing the same and use thereof |
| 06/22/2011 | EP1324771B1 Therapeutic and tolerance inducing antibodies |
| 06/22/2011 | CN1809570B [1,2,4 ]triazolo [1,5-a]pyrimidin-2-ylurea derivative and use thereof |
| 06/22/2011 | CN102105452A Substituted carbinol compound having cyclic linker |
| 06/22/2011 | CN102105161A Recombinant preparation of bromelain inhibitors and bromelain inhibitor precursor |
| 06/22/2011 | CN102105160A Compositions and methods for increasing serum antioxidant concentrations |
| 06/22/2011 | CN102105154A Preparation for oral administration comprising water-extracted chondroitin sulfate and quercetin glycoside |
| 06/22/2011 | CN102102066A Cortex acanthopanacis yellow rice wine and production technology thereof |
| 06/22/2011 | CN102101863A Novel epoxy thiazone compounds and preparation method and application thereof |
| 06/22/2011 | CN102100893A Preparation technology of new integrative formulation of five accumulations powder and production method thereof |
| 06/22/2011 | CN102100892A Preparation technology and production method of integrated Xiaojianzhong decoction novel dosage form |
| 06/22/2011 | CN102100890A Preparation technology of new integrative formulation of cassia twig decoction and production method thereof |
| 06/22/2011 | CN102100888A Preparation technology and production method of new integrative formulation of major green-blue dragon decoction |
| 06/22/2011 | CN102100887A Preparation technology of new integrative formulation of kudzuvine root decoction and preparation method thereof |
| 06/22/2011 | CN102100885A Preparation technology and production method of integrated minor bupleurum decoction novel dosage form |
| 06/22/2011 | CN102100881A Traditional Chinese medicine composition for treating arthralgia |
| 06/22/2011 | CN102100868A Medicinal liquor for treating scapulohumeral periarthritis |
| 06/22/2011 | CN102100867A Musk rheumatism bone paste |
| 06/22/2011 | CN102100861A Chinese medicine for treating children fever of unknown origin |
| 06/22/2011 | CN102100854A Chinese medicinal composition for treating rheumatic arthritis |
| 06/22/2011 | CN102100852A Preparation technology and production method of integrated Baihu decoction novel dosage form |
| 06/22/2011 | CN102100850A Quality control method for refined fructus forsythiae antidotal tablets |
| 06/22/2011 | CN102100832A Traditional Chinese medicine for treating lumbocrural pain |
| 06/22/2011 | CN102100825A Chinese medicine composition for treating pains and preparation method thereof |
| 06/22/2011 | CN102100818A Quality control method for lophanthus antifebrile tablets |
| 06/22/2011 | CN102100811A Chinese medicine capsule for treating rheumatoid arthritis of dogs and cats |
| 06/22/2011 | CN102100809A Chinese medicine preparation for treating trigeminal neuralgia |